Add to Cart View Cart/Checkout More Products

Volume 4, 2000 CD

Six back issues of The International Journal of Pharmaceutical Compounding from 2000 on one convenient CD.
Only $95 per CD.
(Multiple Theme or Library CD orders priced at: 2 to 5 = $85; 6 to 9 = $75; 10 or more = $65 each.)

  • Permanant storage and easy retrieval of IJPC articles, formulations, SOP's and more.
  • Print IJPC articles in color for your marketing needs.

The back issues are stored as a high-resolution, full-color Adobe Portable Document Format (.pdf) file, complete with an electronic Table of Contents.

They may be searched by keyword and printed by the page. Software to read the PDF file is freely available from the Adobe Reader page.

Issues
Volume/IssueDateTitle
Vol. 4 No. 1 January/February 2000 Compounding for Pain Management
Vol. 4 No. 2 March/April 2000 Compounding for Diabetes Patients
Vol. 4 No. 3 May/June 2000 Compounding for the Ear, Nose and Throat
Vol. 4 No. 4 July/August 2000 Compounding for Hospice and Cancer Patients
Vol. 4 No. 5 September/October 2000 Compounding for Immune System Disorders
Vol. 4 No .6 November/December 2000 Compounding for Hormone Replacement Therapy

Articles
Volume/IssuePageTitle
Vol. 4 No. 1 6 Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium
Vol. 4 No. 1 12 The Psychology of Pain
Vol. 4 No. 1 17 Opioids: A Review of the Pharmacology
Vol. 4 No. 1 21 Fibromyalgia
Vol. 4 No. 1 24 Compounding Intrathecal Medications
Vol. 4 No. 1 26 Book Review: The NMDA Receptor
Vol. 4 No. 1 27 Postherpetic Neuralgia
Vol. 4 No. 1 32 Compounding Software: An Evaluation
Vol. 4 No. 1 36 Marketing Your Prescription Compounding Practice: Part One
Vol. 4 No. 1 39 Marketing Tip: Marketing Reps Can Help
Vol. 4 No. 1 40 Profile of a Practice
Vol. 4 No. 1 43 Particulates in Parenterals
Vol. 4 No. 1 44 The Basics of Compounding: Compounding Medication Sticks
Vol. 4 No. 1 45 Clear-Stick Base
Vol. 4 No. 1 45 Styptic Pencil
Vol. 4 No. 1 45 Styptic Pencil (Crayon Type)
Vol. 4 No. 1 45 Analgesic Medication Stick
Vol. 4 No. 1 50 Amitriptyline HCl 2% and Baclofen 2% in PLO
Vol. 4 No. 1 51 Capsaicin 0.075%, Ketamine HCl 2% and Ketoprofen 10% in PLO
Vol. 4 No. 1 52 Capsicum 0.32%, Methyl Salicylate 25% and Menthol 10% Analgesic Cream
Vol. 4 No. 1 53 Clonidine HCl 1-mg/g in VanPen Cream
Vol. 4 No. 1 54 Cyclobenzaprine 1% and Guaifenesin 10% in Speed Gel
Vol. 4 No. 1 55 Dyclonine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches
Vol. 4 No. 1 56 Fentanyl 50-mcg Chewable Gummy Gels
Vol. 4 No. 1 57 Fentanyl 25-mcg/0.1-mL Nasal Spray
Vol. 4 No. 1 58 Morphine Sulfate 2.5-mg/mL Inhalation Solution
Vol. 4 No. 1 59 Shingles Ointment/Cream
Vol. 4 No. 1 60 Stiffening Agents, Featured Excipient:
Vol. 4 No. 1 63 Calculations
Vol. 4 No. 1 65 Calibration of Hot Plates
Vol. 4 No. 1 66 Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Vol. 4 No. 1 69 Naratriptan HCl in Extemporaneously Compounded Oral Suspensions
Vol. 4 No. 1 72 Physicochemical Stability of Compounded Creams Containing alpha-Hydroxy Acids
Vol. 4 No. 2 84 The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Vol. 4 No. 2 86 Sugar Substitutes
Vol. 4 No. 2 88 Complications of Diabetes
Vol. 4 No. 2 91 Transdermal Gels in the Treatment of Diabetic Neuropathy
Vol. 4 No. 2 94 L-Arginine and Ascorbic Acid for Diabetic Foot Ulcers
Vol. 4 No. 2 98 Natural-Product Therapies for Treating Diabetic Neuropathy
Vol. 4 No. 2 100 Patient Handout: Diabetes Management Guidelines
Vol. 4 No. 2 101 Complementary Medicine - A Wellness Plan for People with Diabetes
Vol. 4 No. 2 103 Diabetes Book Reviews
Vol. 4 No. 2 105 Analytical Testing of Extemporaneously Compounded Preparations
Vol. 4 No. 2 110 Natural Estrogens: A Review of the Primary Literature
Vol. 4 No. 2 115 Marketing Your Prescription Compounding Practice: Part Two
Vol. 4 No. 2 120 Profile of a Practice
Vol. 4 No. 2 122 Basics of Compounding: Compounding Solutions
Vol. 4 No. 2 128 Chlorhexidine 0.2% Oral Rinse
Vol. 4 No. 2 129 Coenzyme Q10 200-mg Chewable Troches
Vol. 4 No. 2 130 Diabetic Foot-Care Ointments
Vol. 4 No. 2 131 Diabetic Skin-Ulcer Cream
Vol. 4 No. 2 132 Ketamine HCl 5% and Amitriptyline HCl 2% in PLO
Vol. 4 No. 2 133 Ketamine HCl 10%, Gabapentin 6%, Baclofen 2%, Amitriptyline HCl 2% and Clonidine HCl 0.1% in PLO
Vol. 4 No. 2 134 Lipoic Acid 200-mg Chewable Troches
Vol. 4 No. 2 135 Nifedipine 160-mg/mL in PLO
Vol. 4 No. 2 136 Sugar-Free Suspension Structured Vehicle, USP
Vol. 4 No. 2 137 Vanadyl Sulfate 10-mg Capsules
Vol. 4 No. 2 139 Official Solvents, Featured Excipient:
Vol. 4 No. 2 144 Standard Operating Procedure for Cleaning Glassware
Vol. 4 No. 2 145 Calculations
Vol. 4 No. 2 146 Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution
Vol. 4 No. 2 150 Stability of Ranitidine Hydrochloride with Cefazolin Sodium, Cefbuperazone Sodium, Cefoxitin Sodium and Cephalothin Sodium during Simulated Y-Site Administration
Vol. 4 No. 2 154 Effect of Some Antioxidants on the Color Change of White Lotion
Vol. 4 No. 3 164 Compounding Ear, Nose and Throat Preparations
Vol. 4 No. 3 165 Benzocaine Otic Solution
Vol. 4 No. 3 166 General Nasal Solution Vehicle
Vol. 4 No. 3 167 Desmopressin Acetate Nasal Solution 0.033 mg/mL
Vol. 4 No. 3 167 Saline Nasal Mist
Vol. 4 No. 3 167 Atropine Sulfate 0.5% Nasal Solution
Vol. 4 No. 3 169 Xylometazoline 1-mg/mL HCl Nasal Drops
Vol. 4 No. 3 169 Progesterone 20-mg/mL Nasal Solution
Vol. 4 No. 3 169 Scopolamine Hydrobromide 0.4-mg per 0.1-mL Nasal Solution
Vol. 4 No. 3 171 Xylitol in the Prevention of Otitis Media
Vol. 4 No. 3 174 Xylitol 40% Syrup
Vol. 4 No. 3 174 Xylitol Troches
Vol. 4 No. 3 175 Sildenafil 0.2% Otic Drops
Vol. 4 No. 3 176 Xerostomia
Vol. 4 No. 3 177 Pilocarpine Oral Solution
Vol. 4 No. 3 179 Pharmacological Treatment Options for Snoring
Vol. 4 No. 3 180 Compounding OTC Drugs: A Legal Perspective
Vol. 4 No. 3 183 Needleless Infusion Systems
Vol. 4 No. 3 184 Pharmacy Licensure Requirements
Vol. 4 No. 3 188 Wish You Were Here: Oklahoma Frontier Drug Store Museum
Vol. 4 No. 3 190 Three Drug Stability Lives
Vol. 4 No. 3 196 Cellulose Applications for the Pharmaceutical Industry
Vol. 4 No. 3 199 Marketing Your Prescription Compounding Practice: Part Three
Vol. 4 No. 3 203 Profile of a Practice: Surviving the Competition
Vol. 4 No. 3 204 The Future of Compounding: An Industry Perspective
Vol. 4 No. 3 208 Amphotericin B 100-mg Troches
Vol. 4 No. 3 209 Dimethyl Sulfone 16% Nasal Solution
Vol. 4 No. 3 210 Miconazole 2% Otic Powder
Vol. 4 No. 3 211 Misoprostol 0.001% and Lidocaine 0.5% Oral Rinse
Vol. 4 No. 3 212 Misoprostol 0.0027% Mucoadhesive Powder
Vol. 4 No. 3 213 Mupirocin 1% Nasal Drops
Vol. 4 No. 3 214 Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles
Vol. 4 No. 3 215 Saliva Substitute for Dry Mouth/Throat
Vol. 4 No. 3 216 Stomatitis Preparations
Vol. 4 No. 3 218 Tonicity-Adjusting Agents, Featured Excipient:
Vol. 4 No. 3 221 Calculations
Vol. 4 No. 3 222 Assignment of Beyond-Use Dates
Vol. 4 No. 3 223 Dry Heat Sterilization of Parenteral Oil Vehicles
Vol. 4 No. 3 225 Stability of Morphine-Ketamine Mixtures in 0.9% Sodium Chloride Injection Packaged in Syringes, Plastic Bags and MEDICATION CASSETTEª Reservoirs
Vol. 4 No. 3 229 Simple High-Performance Liquid Chromatographic Method for Simultaneous Determination of Fusidic Acid and Betamethasone Dipropionate in a Cream Formulation
Vol. 4 No. 3 233 Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography
Vol. 4 No. 4 246 Hospice and the Role of the Compounding Pharmacist
Vol. 4 No. 4 250 Nausea and Vomiting in Hospice Patients
Vol. 4 No. 4 253 Ketamine for Pain in Hospice Patients
Vol. 4 No. 4 255 Custom-Making Medications for the Hospice Patient
Vol. 4 No. 4 255 Body-Wash Formula
Vol. 4 No. 4 255 Rinseless Shampoo
Vol. 4 No. 4 255 Dry Mouth Spray
Vol. 4 No. 4 257 Surviving Cancer - How the Compounding Pharmacist Can Help
Vol. 4 No. 4 261 Compounding Using Hazardous Drugs
Vol. 4 No. 4 264 Providing Positive Outcomes through Compounding for Animal Cancer Patients
Vol. 4 No. 4 276 Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Vol. 4 No. 4 278 NADH Capsules
Vol. 4 No. 4 280 Short Communication: Compounding for Implantable Pumps
Vol. 4 No. 4 281 Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Vol. 4 No. 4 287 Profile of a Practice
Vol. 4 No. 4 288 Book Reviews
Vol. 4 No. 4 289 Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations
Vol. 4 No. 4 296 Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection
Vol. 4 No. 4 297 Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO
Vol. 4 No. 4 298 Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection
Vol. 4 No. 4 299 Fentanyl 100-mcg/0.1-mL and Promethazine HCl 12.5-mg/0.1-mL in PLO
Vol. 4 No. 4 300 Fentanyl 35-mcg/mL, Bupivacaine HCl 1-mg/mL and Clonidine HCl 9-mcg/mL Intrathecal Solution
Vol. 4 No. 4 301 Lidocaine HCl 2%, Misoprostol 0.003% and Phenytoin 2.5% Topical Gel for Decubitus Ulcers
Vol. 4 No. 4 302 Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations
Vol. 4 No. 4 303 Morphine Sulfate 20-mg/mL and Clonidine HCl 10-mcg/mL Epidural Injection
Vol. 4 No. 4 304 Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula
Vol. 4 No. 4 305 Ondansetron HCl 8-mg/mL in PLO
Vol. 4 No. 4 306 Capsule and Tablet Diluents, Featured Excipient:
Vol. 4 No. 4 313 Basic Compounding Documentation: The Master Formula Form
Vol. 4 No. 4 314 Calculations
Vol. 4 No. 4 315 Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion
Vol. 4 No. 4 318 Microbiological Stability of a Fentanyl, Bupivacaine and Clonidine Mixture in a 0.9% Sodium Chloride Infusion Stored in Syringes and Reservoirs
Vol. 4 No. 4 320 Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution
Vol. 4 No. 5 334 Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome
Vol. 4 No. 5 338 Clinical Management and Review of Sjogren's Syndrome
Vol. 4 No. 5 339 Sodium Fluoride Gel (0.5% Fluoride)
Vol. 4 No. 5 339 Clotrimazole 10 mg Base A Troche
Vol. 4 No. 5 340 Saliva Substitute
Vol. 4 No. 5 342 Compounding with Beta-1, 3-D-Glucan
Vol. 4 No. 5 346 Psoriasis
Vol. 4 No. 5 349 Probiotics and Their Effect on Leaky Gut Syndrome and Associated Diseases
Vol. 4 No. 5 351 Immune System Disorders: What's new and Interesting in Print and On-Line
Vol. 4 No. 5 356 Transdermal Nifedipine for Wound Healing: Case Reports
Vol. 4 No. 5 359 Wish You Were Here: Marvin Samson Center for the History of Pharmacy, University of the Sciences in Philadelphia
Vol. 4 No. 5 362 Profile of A Practice: Hormone Replacement Therapy in the Heartland
Vol. 4 No. 5 364 Ambulatory Syringe Infusion Devices: A Review - Part 2
Vol. 4 No. 5 371 Basics of Compounding: Compounding Suppositories Part 2
Vol. 4 No. 5 376 Artificial Tears for Dry Eyes
Vol. 4 No. 5 377 Capsicum Oleoresin 0.3% and Ketoprofen 10% in PLO Gel
Vol. 4 No. 5 378 Coal Tar Medication Stick
Vol. 4 No. 5 379 Interferon with 0.1% Nonoxynol-9 Gel
Vol. 4 No. 5 380 Interferon Ophthalmic Solution
Vol. 4 No. 5 381 Pilocarpine HCl 2-mg Troches
Vol. 4 No. 5 382 Psoriasis Nail Treatment
Vol. 4 No. 5 383 Psoriasis Ointment, Heavy Moisturizing
Vol. 4 No. 5 384 Sunscreen Gel-Alcoholic, SPF-15
Vol. 4 No. 5 385 Sunscreen Lotion, SPF-40
Vol. 4 No. 5 386 Providing Care for Diabetic Veterinary Patients
Vol. 4 No. 5 390 Capsule and Tablet Lubricants, Featured Excipient:
Vol. 4 No. 5 393 Calculations
Vol. 4 No. 5 395 Basic Compounding Documentation: The Batch Control Sheet
Vol. 4 No. 5 396 Stability of Hydrocortisone Sodium Succinate After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 4 No. 5 398 Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets
Vol. 4 No. 5 400 Pharmaceutical Profile of Vitamin C Tablets and Capsules
Vol. 4 No .6 414 "Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach
Vol. 4 No .6 421 Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Vol. 4 No .6 424 Book Reviews: Women's Health
Vol. 4 No .6 426 Hormone Replacement Therapy: Selected Recent References
Vol. 4 No .6 429 Testosterone Deficiency in Men: New Treatments for Andropause
Vol. 4 No .6 432 Compounded Testosterone Gels: A Guide for Clinicians and Pharmacists
Vol. 4 No .6 440 Zinc Sulfate Heptahydrate 0.1% Solution
Vol. 4 No .6 440 Managing Zinc Deficiency in an Office Setting
Vol. 4 No .6 442 Disposable Ambulatory Infusion Devices: A Review - Part 3
Vol. 4 No .6 445 On-Line Billing for Custom Compounds: The Third-Party Payor
Vol. 4 No .6 447 Fentanyl Troche Protocol
Vol. 4 No .6 448 Profile of a Practice: Med Specialties Pharmacy
Vol. 4 No .6 450 Wish You Were Here: Donald F. Salvatori California Pharmacy Museum
Vol. 4 No .6 452 Basics of Compounding - Inhalation Preparations
Vol. 4 No .6 455 Albuterol Sulfate 0.5% Inhalant Solution (Preservative Free)
Vol. 4 No .6 455 Flunisolide 0.025% Inhalation Solution (Preservative Free)
Vol. 4 No .6 455 Ipratropium Bromide 0.02% Solution (Preservative Free)
Vol. 4 No .6 455 Terbutaline 0.1% Inhalant Solution (Preservative Free)
Vol. 4 No .6 455 Albuterol-Cromolyn-Betamethasone for Inhalation (Preservative Free)
Vol. 4 No .6 455 Albuterol-Ipratropium for Inhalation (Preservative Free)
Vol. 4 No .6 455 Beclomethasone Dipropionate 0.042% Nasal Solution (Preservative Free)
Vol. 4 No .6 458 Estriol and Estradiol 2.5-mg, Progesterone 50-mg, and Testosterone 1-mg Capsules
Vol. 4 No .6 459 Estriol and Estradiol 1.25, 2.5, and 5-mg (BiEst) Capsules
Vol. 4 No .6 460 Estrogen 0.625-mg/5-g Vaginal Gel
Vol. 4 No .6 461 Progesterone Cycle Pack 35/50/75/100-mg Capsules
Vol. 4 No .6 462 Testosterone 1-mg/0.1-mL Nasal Spray
Vol. 4 No .6 463 Testosterone 1-mg/0.1-mL in a PLO Gel
Vol. 4 No .6 464 Testosterone 1-mg/0.1-mL Topical Vaginal/Scrotal Spray
Vol. 4 No .6 465 Triple Estrogen 2.5-mg/0.1-mL PLO
Vol. 4 No .6 466 Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops
Vol. 4 No .6 467 Triple Estrogen 2.5-mg Tablet Triturates
Vol. 4 No .6 468 Estrogen Use in Dogs: Indications and Complications
Vol. 4 No .6 470 Oleaginous Vehicles, Featured Excipient:
Vol. 4 No .6 473 Calculations
Vol. 4 No .6 474 Assignment of a Beyond-Use Date for Compounded Preparations
Vol. 4 No .6 476 Compatibility and Stability of Linezolid Injection Admixed with Gentamicin Sulfate and Tobramycin Sulfate
Vol. 4 No .6 480 Stability of Nafcillin Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use
Vol. 4 No .6 482 Stability of Levothyroxine Sodium Injection in Polypropylene Syringes